| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $11.9M | +38.3% |
| SG&A Expense | $6.0M | +2.6% |
| Operating Income | -$17.9M | -23.9% |
| Net Income | -$16.0M | -11.9% |
| EPS (Basic) | -$1.47 | -12.2% |
| EPS (Diluted) | -$1.47 | -12.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.9M | -41.0% |
| Short-term Investments | $19.4M | +7.6% |
| Current Assets | $43.3M | -26.2% |
| Total Assets | $43.6M | -25.8% |
| Current Liabilities | $2.7M | -4.3% |
| Total Liabilities | $2.7M | -2.1% |
| Stockholders' Equity | $40.9M | -27.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.3M | -12.4% |
| Capital Expenditures | $19K | -32.7% |
| Investing Cash Flow | -$930K | -618.9% |
| Financing Cash Flow | -$500K | +77.1% |
| Free Cash Flow | -$14.4M | -12.3% |